Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Fortum in connection with the divestment of its recycling and waste business
Mandate

Vinge has advised Fortum in connection with the divestment of its recycling and waste business

December 02, 2024 Environmental Law M&A Corporate Commercial Employment and Benefits Banking and Finance Real Estate and Construction Contentious Regulatory

Vinge, alongside among others Castrén & Snellman, has advised Fortum in connection with the divestment of its recycling and waste business to Summa Equity through its portfolio company NG Group. The debt free purchase price is approximately EUR 800 million.

The recycling and waste business subject to the divestment comprises municipal and industrial waste management and recycling services for handling and recycling of plastics, metals, ash, slag and hazardous waste.  The businesses are located in Finland, Sweden, Denmark and Norway and currently employ approximately 900 employees. 

Vinge’s team mainly consisted of Peter Sundgren and Gustav Wahlberg (M&A), Johan Cederblad and Lina Österberg (Environmental), Martin Boström and Elis Allmark (Corporate Commercial), Sam Seddigh and Agnes Pigg (Employment), Linn Adelwald and Karl-Gustaw Tobola (Banking & Finance), Frida Ställborn (Real Estate) and Daniel Wendelsson, David Olander, Dagne Sabockis and Lovisa Lewin (Regulatory)

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025